Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs, Directed Genomics Partner on NGS-based Target Enrichment Technology

NEW YORK (GenomeWeb) – New England Biolabs and Directed Genomics today announced a partnership to develop new next-generation sequencing-based target enrichment technologies.

The first product to be developed will be a target enrichment technology combining enrichment with NGS library construction into a single, seamless protocol. The partners said the approach is scalable and will enable researchers to convert small amounts of genomic DNA into sequence-ready libraries in about six hours. They added that enrichment is highly specific and enables greater coverage of target regions with fewer sequencing reads than currently available target-capture methods.

Financial and other terms of the deal were not disclosed.

"Partnering with NEB allows us to leverage an extensive knowledgebase of enzyme activities, best-in-class manufacturing practices, and their global commercial footprint," Directed Genomics Founder and President Cynthia Richard said in a statement.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.